Clinical Trial Update: Cannabidiol (CBD) in Adults With ASD [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating cannabidiol (CBD) in adults with Autism Spectrum Disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Autism Spectrum Disorder | Phase 1 | Status: RECRUITING